Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

826
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
826
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.8K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.3K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compressed Virtual Reality Exposure Therapy Used to Habituate a Critical Illness Survivor's Psychological Trauma Symptoms: A Case Report.

Dimensions of critical care nursing : DCCN·2025
Same author

Screening for post-intensive care syndrome: Patient perspectives and a call to action.

The Nurse practitioner·2025
Same author

Intensive Care Unit Memories and Trauma Triggers for Acute Respiratory Distress Syndrome Survivors Hospitalized During the COVID-19 Pandemic.

Dimensions of critical care nursing : DCCN·2025
Same author

A Review of Chlorhexidine Oral Care in Patients Receiving Mechanical Ventilation.

Critical care nurse·2024
Same author

Teaching the Language of Complex Conditions.

Nurse educator·2023
Same author

Screening Out False Participants in Research Recruitment from Social Media Groups.

The American journal of nursing·2023

Related Experiment Video

Updated: May 5, 2026

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
06:52

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project

Published on: November 12, 2009

15.1K

Using Compressed Virtual Reality Exposure Therapy for an Adult Critical Illness Survivor: A Case Report.

Brian C Peach1, Caitlin L Cox2

  • 1Brian C. Peach is an assistant professor in the University of Central Florida College of Nursing and an intensive care unit nurse at Orlando Regional Medical Center, Orlando, Florida.

Critical Care Nurse
|November 30, 2024
PubMed
Summary

Critical illness survivors experiencing posttraumatic stress disorder (PTSD) showed symptom reduction with compressed virtual reality exposure therapy (C-VRET). This innovative therapy may help manage PTSD after intensive care unit stays.

More Related Videos

Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults
06:12

Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults

Published on: February 12, 2020

6.8K
Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

3.9K

Related Experiment Videos

Last Updated: May 5, 2026

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
06:52

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project

Published on: November 12, 2009

15.1K
Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults
06:12

Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults

Published on: February 12, 2020

6.8K
Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

3.9K

Area of Science:

  • Critical care medicine
  • Psychiatry
  • Virtual reality applications

Background:

  • Nearly 25% of adult critical illness survivors develop PTSD.
  • Intensive care unit (ICU) delirium is a known risk factor for PTSD.
  • Compressed virtual reality exposure therapy (C-VRET) uses sensory stimuli for habituation to reduce PTSD symptoms.

Purpose of the Study:

  • To evaluate the effectiveness of C-VRET in treating PTSD in a critical illness survivor.
  • To assess changes in PTSD, depression, physical activity, and resiliency post-therapy.

Main Methods:

  • A single critical illness survivor with ICU delirium and PTSD participated in a C-VRET trial.
  • Standardized screening tests were administered pre-therapy, 2 weeks post-therapy, and 3 months post-therapy.
  • Measures included PTSD symptoms, depression, physical activity, and resiliency.

Main Results:

  • The participant demonstrated significant reductions in PTSD symptom scores (36 to 5) and depression scores (19 to 1).
  • Physical activity scores increased substantially (499 to 4599), and resiliency scores improved (70 to 83).

Conclusions:

  • C-VRET shows promise in reducing PTSD symptoms in critical illness survivors.
  • Highlighting the severity of PTSD in this population underscores the need for effective interventions.
  • Strategies to mitigate ICU delirium and subsequent PTSD are crucial for survivor recovery.